Bauraitė Karolina, Gudaitytė Rita, Maleckas Almantas
Department of Gastroenterology, Medical Academy, Lithuanian University of Health Science, 44307 Kaunas, Lithuania.
Department of Surgery, Medical Academy, Lithuanian University of Health Science, 44307 Kaunas, Lithuania.
Medicina (Kaunas). 2023 Sep 4;59(9):1597. doi: 10.3390/medicina59091597.
: The global pandemic of coronavirus disease (COVID-19), declared on 11 March 2020, had an extensive impact on bariatric patients. The aim of this study was to evaluate short-term weight loss outcomes, changes in eating behaviour, and health-related quality of life (HRQoL) among patients who had Roux-en-Y gastric bypass (RYGB) before and during the COVID-19 pandemic. : This cohort study included 72 patients (Group S) who underwent RYGB surgery in the Surgery Department of the Lithuanian University of Health Sciences during the COVID-19 pandemic in the years 2020-2022. Data for the control group (Group C) of 87 patients (operated on in 2010-2012) were collected from a prospective study. The data referred to the period before and a year after the RYGB. The information about patients' weight changes, hunger, satiety, fullness sensations, appetite, diet, and eating patterns was queried. Eating behaviour and HRQoL evaluation were conducted by the Three-Factor Eating Questionnaire (TFEQ-R18) and the medical outcomes study Short-Form-36 (SF-36), respectively. : One year after the surgery, % excess body mass index loss (%EBMIL) was 77.88 (26.33) in Group S, 76.21 (19.98) in Group C, = 0.663. Patients in Group S tended more to choose snacks between main meals: 79.2% versus 28.7%, < 0.0001. Cognitive restraint significantly increased in Group S from 45.93 (13.37) up to 54.48 (13.76), = 0.001; additionally, significantly worse overall health status was found in Group S compared to Group C, 53.27 (24.61) versus 70.11 (31.63), < 0.0001. Mental HRQoL (50.76 versus 60.52 score, < 0.0001) and social functioning (44.79 versus 57.90, < 0.0001) were worse in Group S. : In this study, the COVID-19 pandemic had no impact on short-term weight loss after RYGB. However, one year after, RYGB patients tended to snack more, and mental HRQoL and social functioning were worse in the study group.
2020年3月11日宣布的新型冠状病毒肺炎（COVID-19）全球大流行对肥胖症患者产生了广泛影响。本研究的目的是评估在COVID-19大流行之前和期间接受 Roux-en-Y 胃旁路术（RYGB）的患者的短期体重减轻结果、饮食行为变化以及健康相关生活质量（HRQoL）。：这项队列研究包括72例患者（S组），他们于2020年至2022年在立陶宛卫生科学大学外科接受了RYGB手术。对照组（C组）87例患者（2010年至2012年接受手术）的数据来自一项前瞻性研究。数据涉及RYGB手术前和手术后一年的时间段。查询了患者体重变化、饥饿感、饱腹感、饱胀感、食欲、饮食和饮食模式的信息。饮食行为和HRQoL评估分别通过三因素饮食问卷（TFEQ-R18）和医学结局研究简表36（SF-36）进行。：手术后一年，S组的超重体重指数损失百分比（%EBMIL）为77.88（26.33），C组为76.21（19.98），P = 0.663。S组患者在正餐之间更倾向于选择零食：79.2% 对28.7%，P < 0.0001。S组的认知抑制从45.93（13.37）显著增加到54.48（13.76），P = 0.001；此外，与C组相比，S组的总体健康状况明显更差，分别为53.27（24.61）和70.11（31.63），P < 0.0001。S组的心理HRQoL（得分50.76对60.52，P < 0.0001）和社会功能（44.79对57.90，P < 0.0001）更差。：在本研究中，COVID-19大流行对RYGB术后的短期体重减轻没有影响。然而，一年后，RYGB患者更倾向于吃零食，并且研究组的心理HRQoL和社会功能更差。
